World Psychiatry

Article	Citations
Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States	441
A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders	409
Perinatal mental health: a review of progress and challenges	399
The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality	333
Addressing mental health needs: an integral part of COVID‐19 response	309
Anxiety and depression among general population in China at the peak of the COVID‐19 epidemic	271
Adaptation of evidence‐based suicide prevention strategies during and after the COVID‐19 pandemic	185
Validation of the new DSM‐5‐TR criteria for prolonged grief disorder and the PG‐13‐Revised (PG‐13‐R) scale	183
Preventive psychiatry: a blueprint for improving the mental health of young people	175
The clinical characterization of the adult patient with depression aimed at personalization of management	169
The promise of machine learning in predicting treatment outcomes in psychiatry	165
Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic met	162
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses	155
Designing and scaling up integrated youth mental health care	153
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors	150
Assessing the public health impacts of legalizing recreational cannabis use: the US experience	149
Transdiagnostic clinical staging in youth mental health: a first international consensus statement	149
The clinical characterization of the patient with primary psychosis aimed at personalization of management	144
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum	142
What is resilience: an affiliative neuroscience approach	141
Preventing suicide in the context of the COVID‐19 pandemic	134
Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types	131
Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas	122
Psychiatry in the age of COVID‐19	116
Hierarchical models of psychopathology: empirical support, implications, and remaining issues	104

COVID‐19 and psychiatrists' responsibilities: a WPA position paper	102
An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in ICD‐11 and DSM‐5	96
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial	95
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum	93
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	92
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis	92
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum	91
The relevance of COVID‐19 pandemic to psychiatry	84
Prioritizing COVID‐19 vaccination for people with severe mental illness	81
“Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry	80
Differential impact of COVID‐related lockdown on mental health in Germany	76
Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review	74
Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population‐based cohort study	70
COVID‐19 health anxiety	70
Psychological processes mediating the association between developmental trauma and specific psychotic symptoms in adults: a systematic review and meta‐analysis	69
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration	69
PHQ‐9: global uptake of a depression scale	68
Emerging experience with selected new categories in the ICD‐11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder	65
The lived experience of psychosis: a bottom‐up review co‐written by experts by experience and academics	64
Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis	63
An update on Individual Placement and Support	62
A pandemic of social isolation?	62
The unified protocol for transdiagnostic treatment of emotional disorders	61
The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first‐episode psychosis services	60
Association of preceding psychosis risk states and non‐psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS‐2 cohort	50
Effectiveness of a WHO self‐help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial	48
Hikikomori: a hidden mental health need following the COVID‐19 pandemic	46
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management	46
Candidate biomarkers in psychiatric disorders: state of the field	46
Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patien	45
Mental health care for older adults: recent advances and new directions in clinical practice and research	45
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants	44
The critical distinction between suicidal ideation and suicide attempts	44
Community‐based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence	44
Mental health problems among COVID‐19 survivors in Wuhan, China	44
The World Mental Health Report: transforming mental health for all	41
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	41
Intergenerational psychiatry: a new look at a powerful perspective	40
Brain networks and cognitive impairment in psychiatric disorders	40
The emergence of cognitive COVID	38
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents	38
Acute psychiatric care: approaches to increasing the range of services and improving access and quality of care	37
New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications	37
Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry	36
The p factor is the sum of its parts, for now	36
The impact of social network sites on mental health: distinguishing active from passive use	36
Testing structural models of psychopathology at the genomic level	34
Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought	34
RDoC at 10: changing the discourse for psychopathology	34
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions	33

The importance of listening to patient preferences when making mental health care decisions	33
Rationale for and usefulness of the inclusion of gaming disorder in the ICD‐11	33
The evolution of Kraepelin's nosological principles	32
The epidemic of fentanyl misuse and overdoses: challenges and strategies	32
School mental health: a necessary component of youth mental health policy and plans	30
Optimizing personalized management of depression: the importance of real‐world contexts and the need for a new convergence paradigm in mental health	30
Anorexia nervosa and the long‐term risk of mortality in women	30
Setting priority areas for WPA’s new triennium	29
The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management	28
Patients with schizophrenia are under‐vaccinated for COVID‐19: a report from Israel	28
Racism and mental health	27
Estimating the real‐world usage of mobile apps for mental health: development and application of two novel metrics	26
The utility of patient‐reported outcome measures in mental health	26
Post‐traumatic stress disorder in the aftermath of COVID‐19 pandemic	26
The alliance in mental health care: conceptualization, evidence and clinical applications	25
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis	25
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review	25
Perinatal mental health and the COVID‐19 pandemic	25
COVID‐19 vaccination uptake in people with severe mental illness: a UK‐based cohort study	24
Internalizing psychopathology and all‐cause mortality: a comparison of transdiagnostic vs. diagnosis‐based risk prediction	24
Implementation of the WPA Action Plan 2020‐2023: an update	23
Thinking too much: rumination and psychopathology	23
The general factor of psychopathology: a comparison with the general factor of intelligence with respect to magnitude and predictive validity	23
Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study	23
Managing dual disorders: a statement by the Informal Scientific Network, UN Commission on Narcotic Drugs	23
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction	23
WPA Action Plan 2020‐2023: a way forward	22
Smartphone relapse prediction in serious mental illness: a pathway towards personalized preventive care	22
WPA educational initiatives: where are we after three years?	22
What is global mental health?	21
Implementation of the WPA Action Plan 2020‐2023	21
Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study	20
Most at‐risk individuals will not develop a mental disorder: the limited predictive strength of risk factors	20
Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls	20
A prevalence assessment of prolonged grief disorder in Syrian refugees	20
Alcohol and the developing adolescent brain	20
Experimental approaches to social disconnection in the general community: can we learn from schizophrenia research?	19
Rethinking the concept of insight	19
The role of self‐compassion in psychotherapy	19
The application of implementation science to community mental health	18
Prenatal mental health and the effects of stress on the foetus and the child. Should psychiatrists look beyond mental disorders?	18
Primary psychosis: more to know, much more to do	18
The network structure of ICD‐11 complex post‐traumatic stress disorder across different traumatic life events	17
	17
Pregnancy specific anxiety: an under‐recognized problem	16
Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis	16
Explaining the missing heritability of psychiatric disorders	16
Alternatives to coercion in mental health care: WPA Position Statement and Call to Action	16
Patterns and correlates of patient‐reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys	16
Accelerating Medicines Partnership® Schizophrenia (AMP®SCZ): developing tools to enable early intervention in the psychosis high risk state	16
A 16‐year follow‐up of patients with serious mental illness and co‐occurring substance use disorder	16
Three questions to consider before developing a mental health app	16
Cardiac vagal tone: a neurophysiological mechanism that evolved in mammals to dampen threat reactions and promote sociality	15
Klerman's “credo” reconsidered:neo‐Kraepelinianism, Spitzer's views, and what we can learn from the past	15
Transforming mental health for all: a critical role for specialists	15
Challenges to mental health services for refugees: a global perspective	15
Empirical severity benchmarks for obsessive‐compulsive disorder across the lifespan	15
Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987	15
Metacognition in psychosis: a renewed path to understanding of core disturbances and recovery‐oriented treatment	14
	14
Psychiatric comorbidity in immune‐mediated inflammatory diseases	14
Meaning in life is a fundamental protective factor in the context of psychopathology	14
Why hierarchical dimensional approaches to classification will fail to transform diagnosis in psychiatry	14
The status of psychodynamic psychotherapy as an empirically supported treatment for common mental disorders – an umbrella review based on updated criteria	14
Person‐centred care planning as foundational to clinical practice	14
From exception to the norm: how mental health interventions have become part and parcel of the humanitarian response	14
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts or power shifts?	13
Risk of new‐onset psychiatric sequelae of COVID‐19 in the early and late post‐acute phase	13
Updates from the WPA Section on Education in Psychiatry	13
Some good news for psychiatry: resource allocation preferences of the public during the COVID‐19 pandemic	13
Suicide‐related Internet search queries in India following media reports of a celebrity suicide: an interrupted time series analysis	13
Future WPA President's public mental health agenda	13
Metabolic side effects in persons with schizophrenia during mid‐ to long‐term treatment with antipsychotics: a network meta‐analysis of randomized controlled trials	13
DSM‐5‐TR: overview of what’s new and what’s changed	13
	12
WPA Scientific Sections: a strengthened backbone for the 2020‐2023 triennium	12
Systems‐based approaches to mental disorders are the only game in town	12
Intimate partner violence and mental health: lessons from the COVID‐19 pandemic	12
Intellectual developmental disorder and autism spectrum disorder in the WPA next triennium mainstream	12
Evidence‐informed is not enough: digital therapeutics also need to be evidence‐based	12

Psychotherapy supervision: an ever‐evolving signature pedagogy	12
New resources for understanding patients’ values in the context of shared clinical decision‐making	12
The role of gamification in digital mental health	12
	11
Rediscovering the mental health of populations	11
Living through interminable adversity: the mental health of the Afghan people	11
	11
Adverse childhood experiences: a meta‐analysis of prevalence and moderators among half a million adults in 206 studies	11
Subjectivity, psychosis and the science of psychiatry	11
Clinical relevance of general and specific dimensions in bifactor models of psychotic disorders	11
Adverse childhood experiences and mental health problems in a nationally representative study of heterosexual, homosexual and bisexual Danes	11
Open access of psychological intervention manuals	11
Selective outcome reporting and the effectiveness of psychotherapies for depression	11
The need for publicly funded research on therapeutic use of psychedelic drugs	10
The practice of psychiatry in health care and sustainable development: progress on the WPA Action Plan 2017‐2020	10
Victimization in people with severe mental health problems: the need to improve research quality, risk stratification and preventive measures	10
The role of countertransference in contemporary psychiatric treatment	10
Advances in virtual care for perinatal mental disorders	10
Meeting the challenges of the new frontier of youth mental health care	10
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention	10
From inter‐brain connectivity to inter‐personal psychiatry	10
Self‐interpretation and meaning‐making processes: re‐humanizing research on early psychosis	10
The social determinants of mental health and disorder: evidence, prevention and recommendations	10
The evolving epidemiology and differential etiopathogenesis of eating disorders: implications for prevention and treatment	10
WPA educational initiatives: reaching different stakeholders in the mental health field	10
The WHO EQUIP Foundational Helping Skills Trainer's Curriculum	9
Supporting psychological well‐being around the time of birth: what can we learn from maternity care?	9
Assessing the impact of environmental factors on the adolescent brain: the importance of regional analyses and genetic controls	9
Being thoughtful about cannabis legalization and social equity	9
Report on the WPA Action Plan at the end of the triennium 2017‐2020	9
Challenges and chances for mental health care in the 21st century	9
A clinically useful conceptualization of emotion regulation grounded in functional contextualism and evolutionary theory	9
Computer‐based virtual reality assessment of functional capacity in primary psychosis	9
World Health Organization's low‐intensity psychosocial interventions: a systematic review and meta‐analysis of the effects of Problem Management Plus andStep‐by‐Step	9
Evolutionary psychiatry: foundations, progress and challenges	9
The ICD‐11 is now officially in effect	9
Prevalence and trends of common mental disorders from 2007‐2009 to 2019‐2022: results from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS), including comparison of prevalence rate	9
Learning from the global response to COVID‐19 to accelerate innovation in mental health trials	9
Update from the WPA Secretary for Education	8
New trends in network modeling of psychopathology	8
The effects of recreational cannabis legalization might depend upon the policy model	8
Glucocorticoid use and risk of suicide: a Danish population‐based case‐control study	8
ICD‐11 sessions at the 19th World Congress of Psychiatry	8
The need for a new generation of digital mental health tools to support more accessible, effective and equitable care	8
Post‐traumatic stress disorder as moderator of other mental health conditions	8
How clinicians can support women in making decisions about psychopharmacological treatments in pregnancy	8
Mortality in persons with recent primary or secondary care contacts for mental disorders in Finland	8
Enabling a youth‐ and mental health‐sensitive greener post‐pandemic recovery	8
The Lifestyle Psychiatry project of the WPA Section on Medicine, Psychiatry and Primary Care	8
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management	8
Paternal perinatal mental disorders are inextricably linked to maternal and child morbidity	8
CopeNYP: a brief remote psychological intervention reduces health care workers’ depression and anxiety symptoms during COVID‐19 pandemic	8
Socioeconomic and sociocultural factors affecting access to psychotherapies: the way forward	8
Youth mental health care in a context of large‐scale collective stress	8
Loneliness and abuse as risk factors for suicide in older adults: new developments and the contribution of the WPA Section on Old Age Psychiatry	8
Postpartum psychosis: an important clue to the etiology of mental illness	8
Tolerability and efficacy of paroxetine and naltrexone for treatment of compulsive sexual behaviour disorder	8
The WPA Code of Ethics for Psychiatry	7
Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel	7
Considering the health and social welfare impacts of non‐medical cannabis legalization	7
Long‐term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta‐analysis	7
Transdiagnostic risk of mental disorders in offspring of affected parents: a meta‐analysis of family high‐risk and registry studies	7
Implementing 21st century “end‐to‐end” and technology‐enhanced care for young people	7
Youth psychiatry: time for a new sub‐specialty within psychiatry	7
20‐year trajectories of positive and negative symptoms after the first psychotic episode in patients with schizophrenia spectrum disorder: results from the OPUS study	7
Bridging between youth psychiatry and child and adolescent psychiatry	7
Coming out proud to erase the stigma of mental illness	7
Cannabis and public health: a global experiment without control	7
The performance of ChatGPT in generating answers to clinical questions in psychiatry: a two‐layer assessment	7
Youth mental health: risks and opportunities in the digital world	7
The retention challenge in remote therapy and learning seen through the lens of the COVID‐19 pandemic	7
The 2021‐2024 Work Plan of WPA Collaborating Centres	7
Moving away from the scarcity fallacy: three strategies to reduce the mental health treatment gap in LMICs	6
Improving mental health through fostering healthy lifestyles in young people: one of the targets in the WPA Action Plan 2023‐2026	6
Trans‐theoretical clinical models and the implementation of precision mental health care	6
Prevention, treatment and care of substance use disorders in times of COVID‐19	6
Dr. Strangelove, or how we learned to stop worrying and love uncertainty	6
Prevention in psychiatry: a role for epigenetics?	6
No service is an island: towards an ecosystem approach to mental health service evaluation	6
The WPA Scientific Sections: a global resource for education, research and care	6
Plan of the WPA Secretary for Scientific Meetings for the triennium 2020‐2023	6
Biomarkers in psychiatric disorders: status quo, impediments and facilitators	6
Mental health economics: bridging research, practice and policy	6
WPA Working Group on Medical Students: current initiatives and future priorities	6
The evolving nosology of personality disorder and its clinical utility	6
The important gain is that we are lumpers and splitters now; it is the splitting that needs our hard work	6
Full speed ahead on indicated prevention of psychosis	6
The relationship between physical and mental health: an update from the WPA Working Group on Managing Comorbidity of Mental and Physical Health	6
WPA activities in the field of publications during the 2017‐2020 triennium	6
Toward a systems‐based approach to understanding the role of the sympathetic nervous system in depression	6
Strengthening the functioning of WPA through its Secretariat	6
Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children	6
Detecting and managing non‐suicidal self‐damaging behaviors	6
A question of continuity: a self‐determination theory perspective on “third‐wave” behavioral theories and practices	6
WPA Working Group on Public Mental Health: objectives and recommended actions	6